Entity

Time filter

Source Type

Santa Monica, CA, United States

Agurs-Collins T.,U.S. National Institutes of Health | Ferrer R.,U.S. National Institutes of Health | Ottenbacher A.,Dr Susan Love Research Foundation | Waters E.A.,University of Washington | And 2 more authors.
Journal of Cancer Education | Year: 2015

Although the availability of direct-to-consumer (DTC) genetic testing has increased in recent years, the general public’s awareness of this testing is not well understood. This study examined levels of public awareness of DTC genetic testing, sources of information about testing, and psychosocial factors associated with awareness of testing in the USA. Data were obtained from the nationally representative 2013 U.S. Health Information National Trends Survey. Guided by a social-cognitive conceptual framework, univariable and multivariable logistic regressions were conducted to identify factors associated with awareness of DTC genetic tests. Of 3185 participants, 35.6 % were aware of DTC genetic tests, with the majority learning about these tests through radio, television, and the Internet. In the final adjusted model, participants with annual incomes of $99,999 or less had lower odds of being aware of DTC genetic testing (ORs ranging from 0.46–0.61) than did those participants with incomes of $100,000 or more. The odds of awareness of DTC genetic tests were significantly higher for those who actively seek cancer information (OR = 1.91, 95 % CI = 1.36–2.69), use the Internet (OR = 1.81, 95 % CI = 1.05–3.13), and have high numeracy skills (OR = 1.67, 95 % CI = 1.17–2.38). It will be critical for healthcare researchers and practitioners to understand predictors and consequences of the public’s awareness of DTC genetic tests, as well as how such awareness may translate into DTC genetic testing uptake, health behavior change, and ultimately disease prevention. © 2015, Springer Science+Business Media New York (outside the USA). Source


Patent
Dr Susan Love Research Foundation | Date: 2012-06-01

One aspect of the present application relates to a covering member for a protruding portion of a patients body. This cover is flexible and collapsible so that it conforms to the shape of the encased portion of the body.


A diagnostic test system, apparatus and method for identifying individuals at risk for developing or having breast cancer by detection of at least one marker associated with increased breast cancer risk in nipple aspirate fluid is provided. A testing device for screening nipple aspirate fluid for the presence of biomarkers associated with breast cancer and methods of identifying individual biomarkers and biomarker panels for evaluating the risk that an individual has developed or will develop breast cancer by assaying nipple aspirate fluid is described.


Trademark
Dr Susan Love Research Foundation | Date: 2015-12-02

Downloadable educational video recordings in the fields of health and disease.


Patent
Dr Susan Love Research Foundation | Date: 2014-09-26

One aspect of the present invention relates to a covering member for a protruding portion of a patients body. This cover is flexible and collapsible so that it conforms to the shape of the encased portion of the body. This prevents the cover from being noticed while it is worn under clothing. The cover can contain a medicament or agent for pretreating a portion of the body before an examination or procedure. When the cover is used to apply a topical anesthetic to a portion of the body for a recommended period of time prior to the procedure or examination commencing, the amount of discomfort experienced by the patient can be significantly reduced compared to the amount experienced by the patient who has the anesthetic applied for just a few moments before the procedure begins. Alternatively, the cover can be used to hold a medicament or agent on the intended portion of the body in order to heal a wound or cure a condition such as a skin rash or the like.

Discover hidden collaborations